Viewing StudyNCT00002765



Ignite Creation Date: 2024-05-05 @ 9:57 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002765
Status: COMPLETED
Last Update Posted: 2015-04-29
First Post: 1999-11-01

Brief Title: Immunotoxin in Treating Patients With Leukemia or Lymphoma
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Leukemia
Keywords:
Name View
splenic marginal zone lymphoma View
recurrent adult Hodgkin lymphoma View
stage IV cutaneous T-cell non-Hodgkin lymphoma View
recurrent cutaneous T-cell non-Hodgkin lymphoma View
Waldenström macroglobulinemia View
recurrent adult acute myeloid leukemia View
recurrent adult acute lymphoblastic leukemia View
relapsing chronic myelogenous leukemia View
refractory chronic lymphocytic leukemia View
refractory hairy cell leukemia View
recurrent small lymphocytic lymphoma View
recurrent grade 1 follicular lymphoma View
recurrent grade 2 follicular lymphoma View
recurrent grade 3 follicular lymphoma View
recurrent adult diffuse small cleaved cell lymphoma View
recurrent adult diffuse mixed cell lymphoma View
recurrent adult diffuse large cell lymphoma View
recurrent adult immunoblastic large cell lymphoma View
recurrent adult lymphoblastic lymphoma View
recurrent adult Burkitt lymphoma View
stage I adult T-cell leukemialymphoma View
stage II adult T-cell leukemialymphoma View
stage III adult T-cell leukemialymphoma View
stage IV adult T-cell leukemialymphoma View
recurrent adult T-cell leukemialymphoma View
prolymphocytic leukemia View
recurrent mantle cell lymphoma View
stage IV mycosis fungoidesSezary syndrome View
recurrent mycosis fungoidesSezary syndrome View
recurrent marginal zone lymphoma View
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
nodal marginal zone B-cell lymphoma View